Home | Acuity News

Technology

Floreo’s FDA Decision on Its VR Autism Therapy Lands This Fall. CEO Vijay Ravindran Says the Pivotal Trial’s Most Striking Result Showed Up in the Parents.

Following a De Novo classification request submitted to the FDA in March and announced in April 2026, virtual reality platform Floreo is awaiting a decision on FloreoRx—which could become the first ...

Featured Healthcare Articles

Regulation

Addiction Treatment Is Shifting From a Daily Pill to a Monthly Shot, and the Economics Are Shifting With It. Long-Acting Injectables Turn Medication Into a Billable Clinical Service.

Regulation

The Workforce That Autism and Disability Services Depend On Is Collapsing, and Almost No One Outside the Field Has Noticed. Direct Support Professionals Are Leaving Faster Than They Can Be Replaced.

Regulation

Camber Health’s Federal Medicaid Lobbying Registration Ended August 31 When McDermott+ Closed Its Lobbying Practice. Filings Show $100,000 Spent on Medicaid Fraud and Reimbursement.

Technology

ABA Intake Automation Found Its Market by Accident: Carelu Was Built to Qualify Sales Leads for Contractors, Then a Cold LinkedIn Message Pointed It Toward Autism Care.

Latest Articles

Technology

Wave Neuroscience’s MeRT Gains FDA Clearance for Adult PTSD on the First Sham-Controlled Trial in the Category. The 510(k) Summary Details the Trial Results, the Safety Profile, and the Reimbursement Path Ahead.

Regulation

IACC Adopts 2026-2028 Autism Strategic Plan With a $747.4 Million Funding Recommendation. NIH Named Profound Autism a Highlighted Funding Topic the Same Morning, and HRSA Filed 41 Corrections.

Regulation

Methamphetamine and Cocaine Now Drive a Third of Overdose Deaths, and There Is No Medication to Treat Them. The Stimulant Crisis Meets a Treatment System Built for Opioids.

Regulation

ABA Staff Retention Starts With the Schedule: Autism FIRST COO Brandi Harris Rebuilt a Virginia Provider Around a Full-Day Clinic Model. It Now Runs Across Nine Clinics.

Technology

Floreo’s FDA Decision on Its VR Autism Therapy Lands This Fall. CEO Vijay Ravindran Says the Pivotal Trial’s Most Striking Result Showed Up in the Parents.

Regulation

Addiction Treatment Is Shifting From a Daily Pill to a Monthly Shot, and the Economics Are Shifting With It. Long-Acting Injectables Turn Medication Into a Billable Clinical Service.

Regulation

The Workforce That Autism and Disability Services Depend On Is Collapsing, and Almost No One Outside the Field Has Noticed. Direct Support Professionals Are Leaving Faster Than They Can Be Replaced.

Regulation

Camber Health’s Federal Medicaid Lobbying Registration Ended August 31 When McDermott+ Closed Its Lobbying Practice. Filings Show $100,000 Spent on Medicaid Fraud and Reimbursement.

Floreo’s FDA Decision on Its VR Autism Therapy Lands This Fall. CEO Vijay Ravindran Says the Pivotal Trial’s Most Striking Result Showed Up in the Parents.

Featured Healthcare Articles

Addiction Treatment Is Shifting From a Daily Pill to a Monthly Shot, and the Economics Are Shifting With It. Long-Acting Injectables Turn Medication Into a Billable Clinical Service.

The Workforce That Autism and Disability Services Depend On Is Collapsing, and Almost No One Outside the Field Has Noticed. Direct Support Professionals Are Leaving Faster Than They Can Be Replaced.

Camber Health’s Federal Medicaid Lobbying Registration Ended August 31 When McDermott+ Closed Its Lobbying Practice. Filings Show $100,000 Spent on Medicaid Fraud and Reimbursement.

ABA Intake Automation Found Its Market by Accident: Carelu Was Built to Qualify Sales Leads for Contractors, Then a Cold LinkedIn Message Pointed It Toward Autism Care.

Get the Latest Behavioral Health News and Articles Direct to Your Inbox

Latest Articles

Wave Neuroscience’s MeRT Gains FDA Clearance for Adult PTSD on the First Sham-Controlled Trial in the Category. The 510(k) Summary Details the Trial Results, the Safety Profile, and the Reimbursement Path Ahead.

IACC Adopts 2026-2028 Autism Strategic Plan With a $747.4 Million Funding Recommendation. NIH Named Profound Autism a Highlighted Funding Topic the Same Morning, and HRSA Filed 41 Corrections.

Methamphetamine and Cocaine Now Drive a Third of Overdose Deaths, and There Is No Medication to Treat Them. The Stimulant Crisis Meets a Treatment System Built for Opioids.

ABA Staff Retention Starts With the Schedule: Autism FIRST COO Brandi Harris Rebuilt a Virginia Provider Around a Full-Day Clinic Model. It Now Runs Across Nine Clinics.

Floreo’s FDA Decision on Its VR Autism Therapy Lands This Fall. CEO Vijay Ravindran Says the Pivotal Trial’s Most Striking Result Showed Up in the Parents.

Addiction Treatment Is Shifting From a Daily Pill to a Monthly Shot, and the Economics Are Shifting With It. Long-Acting Injectables Turn Medication Into a Billable Clinical Service.

The Workforce That Autism and Disability Services Depend On Is Collapsing, and Almost No One Outside the Field Has Noticed. Direct Support Professionals Are Leaving Faster Than They Can Be Replaced.

Camber Health’s Federal Medicaid Lobbying Registration Ended August 31 When McDermott+ Closed Its Lobbying Practice. Filings Show $100,000 Spent on Medicaid Fraud and Reimbursement.

Article Categories